BWAY
BrainsWay Ltd.
BWAY offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
LLY
Eli Lilly and Company
LLY has the edge over BWAY overall, supported by stronger modeled upside and stronger valuation.
BWAY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Stable | |
| Healthy |
BWAY's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
BWAY PE Valuation
BWAY has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
BWAY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for BWAY, with profitability improving.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
BWAY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.37 | +147% |
| Q1 2026 | $0.28 | +133% |
| Q4 2025 | $0.18 | +80% |
| Q3 2025 | $0.15 | +114% |
| Q2 2025 | $0.15 | +650% |
| Q1 2025 | $0.12 | +$0.17 |
| Q4 2024 | $0.10 | +$0.22 |
| Q3 2024 | $0.07 | +$0.32 |
BWAY's earnings per share have climbed steadily: $0.37 over the past year, up 147% from the year before, and higher year over year for 12 quarters in a row.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
BWAY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $17.4M | +38% |
| Q1 2026 | $15.5M | +35% |
| Q4 2025 | $14.5M | +27% |
| Q3 2025 | $13.5M | +29% |
| Q2 2025 | $12.6M | +26% |
| Q1 2025 | $11.5M | +27% |
| Q4 2024 | $11.4M | +26% |
| Q3 2024 | $10.5M | +26% |
BWAY's revenue has grown year over year for 12 quarters in a row: $17M last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +9.4 points |
| Q1 2026 | 13% | +7.9 points |
| Q4 2025 | 13% | +9.4 points |
| Q3 2025 | 9.3% | +6.6 points |
| Q2 2025 | 4.6% | -1.3 points |
| Q1 2025 | 5% | +4 points |
| Q4 2024 | 3.8% | -108 points |
| Q3 2024 | 2.7% | +4.3 points |
BWAY's operating margin was 14% last quarter, up 9.4 points from the same quarter a year ago, near the top of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over BWAY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over BWAY on profitability, with a higher operating margin.
BWAY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.5M | -51% |
| Q1 2026 | $402K | -90% |
| Q4 2025 | -$759K | -130% |
| Q3 2025 | $586K | -40% |
| Q2 2025 | $11.2M | +2139% |
| Q1 2025 | $4M | +62% |
| Q4 2024 | $2.6M | +27% |
| Q3 2024 | $978K | +16% |
BWAY still generates free cash flow, though less than at its 2025 peak: $6M over the past year.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over BWAY on cash flow, with more consistent year-over-year improvement.
BWAY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.1% | +981K shares |
| 1 year | -47% | -17.7M shares |
| 3 years | -40% | -13.1M shares |
| 5 years | -39% | -12.8M shares |
| Available history | -8.5% | -1.9M shares |
BWAY has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BWAY hasn't bought back shares in the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
BWAY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.5x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -5.2x | Net Cash |
| Q3 2025 | -6.6x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -10.0x | Net Cash |
| Q4 2024 | -11.9x | Net Cash |
| Q3 2024 | -8.6x | Net Cash |
BWAY has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
BWAY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 5.3 | Oversold |
BWAY's weekly RSI is 30 (oversold) and its Stochastic is 5 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
BWAY PE vs Healthcare Sector
| Metric | BWAY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BWAY has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
BWAY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.6 | 12% below |
| 20 week MA | $13.6 | 25% below |
| 50 week MA | $13.2 | 22% below |
| 100 week MA | $9.61 | 6.7% above |
| 200 week MA | $6.08 | 69% above |
BWAY has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 69% above its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over BWAY on trend strength, trading above more of its moving averages.
BWAY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.85 | $3.09 | -36% |
| 2021 | $3.09 | $3.76 | +22% |
| 2022 | $3.76 | $1.08 | -71% |
| 2023 | $1.08 | $3.24 | +200% |
| 2024 | $3.24 | $4.57 | +41% |
| 2025 | $4.57 | $9.69 | +112% |
| 2026 YTD | $9.69 | $10.3 | +5.8% |
BWAY's yearly returns have swung widely, from +200% in 2023 to −71% in 2022. It's up 5.8% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over BWAY on returns for 2026, with the stronger performance.